Get started
Silexion Therapeutics CorpSilexion Therapeutics CorpSilexion Therapeutics Corp

Silexion Therapeutics Corp

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

SLXN fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
SLXN has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company